| Vaibhav Goswami, MD | |
|
301 S 7th Ave Ste 3020, West Reading, PA 19611-1494 | |
| (484) 628-4925 | |
| Not Available |
| Full Name | Vaibhav Goswami |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 10 Years |
| Location | 301 S 7th Ave Ste 3020, West Reading, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336699859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD469257 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reading Hospital | 7618886490 | 102 |
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
North Carolina State University researchers have used silver nanowires to develop wearable, multifunctional sensors that could be used in biomedical, military or athletic applications, including new prosthetics, robotic systems and flexible touch panels.
This month in Rio de Janeiro, the global tobacco industry's annual conference features a special session on what many are seeing as its Armageddon: plain, generic packaging. All packs are identical except for the brand name, printed in standard font. No colours, no logos, no box variations. Nothing but the brand and the health warning.
Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 8 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
North Carolina State University researchers have used silver nanowires to develop wearable, multifunctional sensors that could be used in biomedical, military or athletic applications, including new prosthetics, robotic systems and flexible touch panels.
This month in Rio de Janeiro, the global tobacco industry's annual conference features a special session on what many are seeing as its Armageddon: plain, generic packaging. All packs are identical except for the brand name, printed in standard font. No colours, no logos, no box variations. Nothing but the brand and the health warning.
Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 8 days ago
| Entity Name | Reading Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992387518 PECOS PAC ID: 7618886490 Enrollment ID: O20040408001076 |
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
North Carolina State University researchers have used silver nanowires to develop wearable, multifunctional sensors that could be used in biomedical, military or athletic applications, including new prosthetics, robotic systems and flexible touch panels.
This month in Rio de Janeiro, the global tobacco industry's annual conference features a special session on what many are seeing as its Armageddon: plain, generic packaging. All packs are identical except for the brand name, printed in standard font. No colours, no logos, no box variations. Nothing but the brand and the health warning.
Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vaibhav Goswami, MD 301 S 7th Ave Ste 3020, West Reading, PA 19611-1494 Ph: (484) 628-4925 | Vaibhav Goswami, MD 301 S 7th Ave Ste 3020, West Reading, PA 19611-1494 Ph: (484) 628-4925 |
News Archive
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the results from their real-world study XALIA showing that, in people with deep vein thrombosis (DVT), the rates of major bleeding and recurrent blood clots for XARELTO (rivaroxaban) in routine clinical practice were generally consistent with those observed in Phase 3 research.
North Carolina State University researchers have used silver nanowires to develop wearable, multifunctional sensors that could be used in biomedical, military or athletic applications, including new prosthetics, robotic systems and flexible touch panels.
This month in Rio de Janeiro, the global tobacco industry's annual conference features a special session on what many are seeing as its Armageddon: plain, generic packaging. All packs are identical except for the brand name, printed in standard font. No colours, no logos, no box variations. Nothing but the brand and the health warning.
Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
› Verified 8 days ago
Dr. Mohammad Ali Khoshnoodi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave Ste 210, West Reading, PA 19611 Phone: 484-628-4656 | |
Dr. John Gurski, D.O, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-9049 | |
Dr. Jayesh P Patel, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-4879 | |
Jaswin Singh, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 | |
Kolin Diane Good, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6th & Spruce Streets, Reading Hospital, West Reading, PA 19611 Phone: 484-628-8070 Fax: 484-628-5289 | |
Dr. Lawrence A Brzozowski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 S 7th Ave, 210, West Reading, PA 19611 Phone: 484-628-4656 Fax: 484-628-4657 | |
Wajihah Memon, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 S 5th Ave, West Reading, PA 19611 Phone: 484-628-8000 |